Literature DB >> 9266735

The impact of inpatient rehabilitation on progressive multiple sclerosis.

J A Freeman1, D W Langdon, J C Hobart, A J Thompson.   

Abstract

One of the primary aims of rehabilitation for patients with multiple sclerosis (MS) is to reduce their levels of disability and handicap, yet little systematic research into the outcomes of this intervention has been undertaken. This stratified, randomized, wait-list controlled study evaluated the effectiveness of a short period of multidisciplinary inpatient rehabilitation in people with MS. Sixty-six patients in the progressive phase of the disease were assessed at 0 and 6 weeks with validated measures of impairment (Expanded Disability Status Scale and Functional Systems), disability (Functional Independence Measure), and handicap (London Handicap Scale). Both groups were comparable in terms of age, sex, disease duration and severity, disability, and handicap. At the end of 6 weeks, although the level of impairment in both groups remained the same, those who participated in a short period of inpatient rehabilitation (average of 25 days) significantly improved their level of disability and handicap compared with those in the wait-list control group. Despite unchanging impairment, inpatient rehabilitation resulted in reduced disability and handicap in patients with progressive MS.

Entities:  

Mesh:

Year:  1997        PMID: 9266735     DOI: 10.1002/ana.410420216

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  44 in total

Review 1.  Recent advances in rehabilitation.

Authors:  D T Wade; B A de Jong
Journal:  BMJ       Date:  2000-05-20

Review 2.  Neurological rehabilitation: from mechanisms to management.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

3.  Symptomatic management and rehabilitation in multiple sclerosis.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 4.  Supporting individuals with disabling multiple sclerosis.

Authors:  Jeremy Gibson; Andrew Frank
Journal:  J R Soc Med       Date:  2002-12       Impact factor: 5.344

Review 5.  Neurorehabilitation in multiple sclerosis--what is the evidence-base?

Authors:  Jürg Kesselring
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

6.  Neutralizing antibodies against interferon-Beta.

Authors:  Per Soelberg Sorensen
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

7.  The impact of inpatient neurorehabilitation on psychological well-being on discharge and at 3 month follow-up.

Authors:  Rory J O'Connor; Stefan J Cano; Alan J Thompson; E Diane Playford
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

8.  Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study.

Authors:  D T Wade; H Gage; C Owen; P Trend; C Grossmith; J Kaye
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

9.  A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment.

Authors:  J Craig; C A Young; M Ennis; G Baker; M Boggild
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

10.  Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.

Authors:  Fary Khan; Bhasker Amatya; Jürg Kesselring
Journal:  J Neurol       Date:  2013-04-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.